Drug Catalog - Product Detail
ORPHENADRINE CITRATE FOR INJECTION INJECT. 30MG/ML 10X2ML
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 17478-0538-02 | AKORN | 2 | 30MG/ML | SOLUTION |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION: Orphenadrine citrate is the citrate salt of orphenadrine ((±)-N, N-Dimethyl- 2-[(o-methyl-a-phenylbenzyl)oxy]ethylamine citrate (1:1)) with a molecular weight of 461.50; empirical formula C18H23NO•C6H8O7. The structural formula of orphenadrine citrate is: It occurs as a white, crystalline powder having a bitter taste. It is practically odorless; sparingly soluble in water, slightly soluble in alcohol. Orphenadrine citrate injection contains 60 mg of orphenadrine citrate in aqueous solution in each vial. Orphenadrine citrate injection also contains: sodium chloride USP 5.8 mg; sodium metabisulfite NF, 2.0 mg; sodium hydroxide NF, to adjust pH (5.0 to 6.0); and water for injection USP, q.s. to 2 mL. orp01-0006-01
How Supplied
HOW SUPPLIED: INJECTION: Boxes of 10 (NDC 17478-538-02) 2 mL vials, each vial containing 60 mg of orphenadrine citrate in aqueous solution. Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Single-dose vial. Discard unused portion. AKORN Manufactured by: Akorn, Inc. Lake Forest, IL 60045 RF00N Rev. 01/19
Indications & Usage
INDICATIONS AND USAGE: Orphenadrine citrate injection is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of the drug has not been clearly identified, but may be related to its analgesic properties. Orphenadrine citrate does not directly relax tense skeletal muscles in man.
Dosage and Administration
DOSAGE AND ADMINISTRATION: INJECTION: Adults - One 2 mL vial (60 mg) intravenously or intramuscularly; may be repeated every 12 hours.